<DOC>
	<DOCNO>NCT01931839</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety long-term treatment lumacaftor combination ivacaftor people 12 year older Cystic Fibrosis .</brief_summary>
	<brief_title>A Phase 3 Rollover Study Lumacaftor Combination With Ivacaftor Subjects 12 Years Older With Cystic Fibrosis</brief_title>
	<detailed_description>This Phase 3 , parallel group , multicenter , rollover study subject CF homozygous heterozygous F508del CFTR mutation previously participate Study 103 , Study 104 , Cohort 4 Study 102</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Signed informed consent form ( ICF ) , appropriate , sign assent form . Subjects enter Part A Treatment Cohort : Completed 24 week study drug treatment Study 103 Study 104 elect enroll Part A treatment cohort . Subjects enter Part B Treatment Cohort : Completed 56 day study drug treatment Cohort 4 Study 102 elect enroll Part B treatment cohort . Subjects enter Part A Observational Cohort : Completed 24 week study drug treatment Study 103 Study 104 , elect enroll Part A Treatment Cohort qualify enroll Part A treatment cohort . Willing remain stable CF medication regimen end study ( Part A Part B Treatment Cohorts ) . Any comorbidity laboratory abnormality , opinion investigator , might confound result study pose additional risk administer study drug subject ( e.g. , cirrhosis portal hypertension ) . Pregnant nursing female . Females childbearing potential must negative pregnancy test Day 1 Visit . History drug intolerance prior study would pose additional risk subject opinion investigator Vertex . History poor compliance study drug and/or procedures previous study deem investigator . Participation investigational drug trial ( include study investigate lumacaftor and/or ivacaftor , study require blood collection without administration study drug )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>